Inhibikase Therapeutics, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
IKT on Nasdaq
Location
3350 Riverwood Parkway Se, Suite 1900, Atlanta, GA

Insiders trading volume in the past year

Inhibikase Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sands Capital Life Sciences Pulse Fund II, L.P. 10%+ Owner $15M Oct 21, 2024
Bellini Roberto Francesco Director $2M +$2M Oct 21, 2024
Amit Munshi Director $500K +$500K Oct 21, 2024
Arvind Kush Director $199K +$199K Oct 21, 2024
Joseph Frattaroli Cheif Financial Officer $38.5K Mar 1, 2023
Elizabeth G. O'Farrell Director Jun 24, 2022
Paul C. Grint Director Jul 16, 2024
Garth Lees-Rolfe Chief Financial Officer Apr 1, 2024
Milton H. Werner President and CEO, Director, 10%+ Owner Apr 1, 2024
David Canner Director Oct 21, 2024
Roy Lester Freeman Director Jul 16, 2024
Gisele Dion Director Jul 16, 2024
Dennis N. Berman Director Jul 16, 2024

Recent Insider Transactions by Companies or Individuals for Inhibikase Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.